All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

26

Reset

26 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • ZasocitinibTAK- 279, NDI-034858Phase 317 trials

    Takeda · Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease

  • PovorcitinibINCB054707, INCB54707Phase 312 trials

    Incyte · Hidradenitis Suppurativa (HS), NonSegmental Vitiligo, Prurigo Nodularis

  • MK-7240PRA023, TulisokibartPhase 310 trials

    Merck & Co. · Ulcerative Colitis, Psoriatic Arthritis, Crohn's Disease

  • LutikizumabABT-981Phase 38 trials

    AbbVie · Hidradenitis Suppurativa, Atopic Dermatitis, Rheumatoid Arthritis

  • OlatorepatideHS-20094Phase 38 trials

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · Type 2 Diabetes, Overweight or Obesity, Overweight or Obesity Without Diabetes

  • SonelokimabPhase 37 trials

    MoonLake Immunotherapeutics AG · Hidradenitis Suppurativa, Arthritis, Psoriatic

  • BFB759Phase 32 trials

    Bluefin Biomedicine, Inc. · Atopic Dermatitis (AD), Hidradenitis Suppurativa (HS)

  • brivekimigSAR442970Phase 25 trials

    Sanofi · Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion, Type 1 Diabetes Mellitus

  • MAS825ArumakimigPhase 24 trials

    Novartis · NLRC4-GOF, AIFEC (Autoinflammation With Infantile Enterocolitis), XIAP Deficiency, CDC42 Mutations, Still´s Disease, VEXAS Syndrome

  • LT-002-158Phase 23 trials

    Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. · Atopic Dermatitis (AD), Hidradenitis Suppurativa (HS)

  • ORKA-002Phase 23 trials

    Oruka Therapeutics, Inc. · Plaque Psoriasis, Hidradenitis Suppurativa (HS)

  • QLS12010Phase 23 trials

    Qilu Pharmaceutical Co., Ltd. · Adults With Moderate-to-severe Hidradenitis Suppurativa, Moderate-to-severe Atopic Dermatitis, Rheumatoid Arthritis (RA)

  • CIT-013Phase 22 trials

    Citryll BV · Hidradenitis Suppurativa (HS), Rheumatoid Arthritis

  • CIT-013 dosePhase 22 trials

    Citryll BV · Hidradenitis Suppurativa (HS), Rheumatoid Arthritis

  • EltrekibartLY3041658Phase 22 trials

    Eli Lilly · Ulcerative Colitis, Ulcerative Colitis Chronic, Hidradenitis Suppurativa

  • HB0043Phase 22 trials

    Shanghai Huaota Biopharmaceutical Co., Ltd. · Acne Vulgaris, Hidradenitis Suppurativa

  • SL-325Phase 22 trials

    Shattuck Labs, Inc. · Crohn's Disease, Hidradenitis Suppurativa (HS)

  • SPY002-072SPY072Phase 22 trials

    Spyre Therapeutics, Inc. · Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis

  • TibulizumabZB-106Phase 22 trials

    Zura Bio Inc · Hidradenitis Suppurativa (HS), Systemic Sclerosis (SSc), Scleroderma

  • iscalimabCFZ533Phase 21 trial

    Novartis · Hidradenitis Suppurativa

  • LAD191Phase 21 trial

    Almirall, S.A. · Hidradenitis Suppurativa

  • LAD328Phase 21 trial

    Almirall, S.A. · Hidradenitis Suppurativa

  • LYS006Phase 21 trial

    Novartis · Hidradenitis Suppurativa

  • NAV-240Phase 21 trial

    Navigator Medicines, Inc. · Hidradenitis Suppurativa (HS)

  • SAR445399Phase 21 trial

    Sanofi · Hidradenitis Suppurativa

  • SCT650CPhase 21 trial

    Sinocelltech Ltd. · Hidradenitis Suppurativa (HS)

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.